The rapid digital transformation of microbiology has led to unprecedented laboratory automation, generating vast data and advancing analytical capabilities. However, integrating complex artificial intelligence models with high-throughput systems introduces challenges in understanding system functions, ensuring reproducibility, and maintaining trust in automated outputs. This chapter presents a framework that integrates Explainable Artificial Intelligenceand Digital Twin technologies to create intelligent microbial laboratories. Through real-time automation, sensor-based data acquisition, computational modeling, and interpretable AI methods, the system continuously monitors, simulates, and optimizes microbial experiments. This approach improves experimental reliability while supporting human decision-making in clinical microbiology. The chapter further outlines practical workflows, architectural designs, and use cases demonstrating how explainable digital twins transform automated laboratories into adaptive, transparent, and trustworthy platforms for scientific discovery.
Breast cancer is the most frequently diagnosed cancer globally, annually affecting around 2 million women. Situation is getting worse with rising incidence linked to improved detection, risk factors, and enhanced registration systems. Conventional treatments like surgery, chemotherapy, radiotherapy, and hormonal therapy with several limitations are replaced by approaches like immunotherapy, HER2-targeted therapies, and nanotechnology offering improved outcomes, in metastatic cases. Risk factors range from lifestyle (alcohol, obesity, inactivity, smoking), to hormonal imbalance (early menarche, late menopause, nulliparity), to genetic aspects (BRCA1/2, TP53), to environmental determinants as well. Prognostic biomarkers now lead precision medicine: PR, ER, and HER2 stands strong as established pillars, while circulating tumor DNA, and immune-related markers such as PD-L1 offer profound perceptions into treatment response and disease progression. State-of-the-art treatment integrates traditional modalities like surgery, radiotherapy, and chemotherapy with targeted and immune-based therapies. Endocrine agents, PARP inhibitors, HER2-directed monoclonal antibodies, and checkpoint inhibitors exemplify the architype swing toward personalized, mechanism-based interventions. The insight underscores the need for twin tactics, leveraging molecular detections for precision oncology while guaranteeing impartial global access to modern therapies. Future progress depends on translational research, and biomarker validation that bridge the gap between innovation and accessibility.
Gradient boosting models predict retail demand effectively, yet inventory planners distrust predictions they cannot interpret. This paper addresses the trust gap through a four-level Explainable AI (XAI) framework that pairs LightGBM prediction with layered interpretability: Permutation Feature Importance (PFI) for global ranking, Partial Dependence Plots (PDP) for marginal effects, SHapley Additive exPlanations (SHAP) for instance-level attribution, and Individual Conditional Expectation (ICE) plots for heterogeneity detection. ICE analysis, the key extension beyond prior work, reveals when averaged trends mask divergent product behavior, justifying segment-specific inventory policies. Validated on the UCI Online Retail II dataset with 41 engineered features, the proposed model achieves RMSE of 33.71 and R(2 )of 0.243 on inherently intermittent stock-keeping unit (SKU)-level daily demand, significantly outperforming most baselines (paired t-test, p <0.001; CatBoost not significant, p = 0.917). Ablation experiments confirm rolling statistics as the dominant feature group ( Delta R-2=-0.064 upon removal). ICE heterogeneity analysis identifies product clusters where temporal features produce opposite effects, demonstrating that uniform reorder policies systematically misallocate inventory for specific segments.
Forecasting intermittent and lumpy demand is a significant supply chain challenge, as traditional metrics like MAPE and RMSE are unreliable for such sparse data. This study provides a comprehensive comparative evaluation of forecasting methods, benchmarking statistical, machine learning, and deep learning models across 3,671 intermittent time series. We utilized robust, cost-sensitive metrics like SPEC, alongside MAAPE and MWQL, for a more accurate assessment. Our results demonstrate that deep learning models significantly outperform traditional and machine learning approaches. DeepAR achieved the best probabilistic forecasting, making it ideal for managing uncertainty. In contrast, the Deep Renewal Hybrid model excelled in point accuracy. Statistical methods remained competitive in cost-sensitive scenarios, while machine learning models underperformed. This research establishes a practical decision framework to guide practitioners in selecting the optimal model based on specific operational priorities, whether they are focused on uncertainty, accuracy, or cost. This provides actionable, evidence-based recommendations for real-world supply chain implementation.
Business requirements for enterprise software systems are rarely captured in structured form; the logic resides instead in source code, configuration files, and institutional memory. When these systems must be migrated, extended, or audited, the absence of formal requirements artifacts forces teams into expensive, knowledge-losing manual reverse engineering. This paper presents an agentic framework that autonomously generates Business Requirements Documents (bRDs) through reverse engineering of undocumented enterprise software. Seven specialized agents collaborate to discover user journeys, extract business rules, and synthesize a locked bRD from code, test suites, configuration, and available documentation, supported by static analysis tools, guided by embedded expert practitioner cognitive models, and overseen by human reviewers at controlled escalation points. Measured on actual execution traces across a real enterprise deployment, the framework generates comprehensive bRDs in under nine minutes per service, with extracted rules independently corroborated against real production defect records. In a comparable prior migration to the same target architecture, delivery required over two years; on the present programme the framework achieves a cost reduction exceeding 98